These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1358 related items for PubMed ID: 36689018

  • 1. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C, Yan Y, Yang S, Wang Z, Wu Z, Li Z, Zhang Z, Lin Y, Li P, Hu H.
    Funct Integr Genomics; 2023 Jan 23; 23(1):46. PubMed ID: 36689018
    [Abstract] [Full Text] [Related]

  • 2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J, Qin D, Tao Z, Wang B, Xie Y, Wang Y, Li B, Cao J, Qiao X, Zhong S, Hu X.
    Front Immunol; 2022 Jan 23; 13():1056932. PubMed ID: 36479114
    [Abstract] [Full Text] [Related]

  • 3. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer.
    Shen C, Chai W, Han J, Zhang Z, Liu X, Yang S, Wang Y, Wang D, Wan F, Fan Z, Hu H.
    Front Immunol; 2023 Jan 23; 14():1213947. PubMed ID: 37965307
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures.
    Dong Y, Wu X, Xu C, Hameed Y, Abdel-Maksoud MA, Almanaa TN, Kotob MH, Al-Qahtani WH, Mahmoud AM, Cho WC, Li C.
    Aging (Albany NY); 2024 Feb 01; 16(3):2591-2616. PubMed ID: 38305808
    [Abstract] [Full Text] [Related]

  • 7. Construction and Validation of a Prognostic Model Based on Pyroptosis-related Genes in Bladder Cancer.
    Shen C, Han C, Li Z, Yan Y, Li C, Chen H, Fan Z, Hu H.
    Comb Chem High Throughput Screen; 2024 Feb 01; 27(16):2335-2349. PubMed ID: 37849225
    [Abstract] [Full Text] [Related]

  • 8. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z, Liu H, Gong Y, Cheng Y.
    Eur J Med Res; 2022 Dec 29; 27(1):317. PubMed ID: 36581948
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L, Wang L, He P.
    Front Genet; 2022 Dec 29; 13():1064432. PubMed ID: 36568383
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer.
    Cao M, Cao Y, Xue S, Zhang Q, Zhang H, Xue W.
    Altern Ther Health Med; 2024 Apr 29; 30(4):130-138. PubMed ID: 38518167
    [Abstract] [Full Text] [Related]

  • 13. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C, Liu D, Wang F, Xie J, Liu Y, Wang H, Rong J, Xie J, Wang J, Zeng R, Zhou F, Xie Y.
    Front Med (Lausanne); 2022 Apr 29; 9():925661. PubMed ID: 35872794
    [Abstract] [Full Text] [Related]

  • 14. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C, Liu D, Wang F, Xie J, Liu Y, Wang H, Rong J, Xie J, Wang J, Zeng R, Zhou F, Peng J, Xie Y.
    Front Cell Dev Biol; 2022 Apr 29; 10():971992. PubMed ID: 36081904
    [Abstract] [Full Text] [Related]

  • 15. Anoikis-related subtype and prognosis analyses based on bioinformatics, and an expression verification of ANGPTL4 based on experiments of lung adenocarcinoma.
    Shen X, Xie J, Liu S, Cai Y, Yuan S, Uehara Y, Zhu D, Zheng M.
    J Thorac Dis; 2024 Aug 31; 16(8):5361-5378. PubMed ID: 39268091
    [Abstract] [Full Text] [Related]

  • 16. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B, Tong F, Zhai C, Wang L, Liu Y, Wang J.
    Dis Markers; 2021 Aug 31; 2021():3385058. PubMed ID: 34721733
    [Abstract] [Full Text] [Related]

  • 17. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
    Chen Y, He J, Jin T, Zhang Y, Ou Y.
    J Cancer Res Clin Oncol; 2023 Dec 31; 149(18):16905-16929. PubMed ID: 37740762
    [Abstract] [Full Text] [Related]

  • 18. Identification of a Nuclear Mitochondrial-Related Multi-Genes Signature to Predict the Prognosis of Bladder Cancer.
    Jiang X, Xia Y, Meng H, Liu Y, Cui J, Huang H, Yin G, Shi B.
    Front Oncol; 2021 Dec 31; 11():746029. PubMed ID: 34692528
    [Abstract] [Full Text] [Related]

  • 19. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T, Luo Y, Liu J, Liu F, Ma Z, Liu G, Li H, Wen J, Chen C, Zeng X.
    Front Oncol; 2023 Dec 31; 13():1182434. PubMed ID: 37346073
    [Abstract] [Full Text] [Related]

  • 20. Eleven inflammation-related genes risk signature model predicts prognosis of patients with breast cancer.
    Hu H, Yuan S, Fu Y, Li H, Xiao S, Gong Z, Zhong S.
    Transl Cancer Res; 2024 Jul 31; 13(7):3652-3667. PubMed ID: 39145071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.